Medtronic Announces U.S. Launch of Spine Essentials Demonstrating Its Commitment to Create Value in Healthcare
May 19 2016 - 9:00AM
New Platform
Increases Efficiencies and Reduces Costs
Associated with Common Spinal Surgery
DUBLIN and DALLAS - May 19, 2016
- Medtronic plc (NYSE: MDT) announced the U.S. launch of Spine
Essentials(TM), a new platform of spinal implants and instruments
designed to make the most common cervical spine fusion procedures
more efficient and help hospital systems manage costs, while
maintaining quality. The goal of Spine Essentials is to help
surgeons and their staffs streamline the most common spinal
fusions, by providing the exact tools in the right quantities
needed to perform 1- and 2-level cervical spinal fusions, while
reducing the costs and time required for instrument sterilization,
case set up and inventory management.
Spine Essentials was developed in collaboration
with leading surgeons and administrators and launched today at the
Ambulatory Surgical Center Association (ASCA) annual meeting in
Dallas.
"As a surgeon who routinely performs these
types of surgeries, it's helpful to optimize the implants and
tools, so we're being as efficient as possible to provide the best
care possible to our patients," said Dr. Richard N.W. Wohns,
orthopedic surgeon at neoSpine in Puyallup, WA and one of the
physicians who collaborated with Medtronic to develop the
platform.
To develop Spine Essentials, Medtronic partnered with healthcare
systems across the U.S. to evaluate unmet needs and identify
efficiencies. Spine Essentials implant sets include the most
commonly used implant sizes for 1- and 2-level fusions of the neck
(anterior cervical discectomy and fusions) and are sterile packaged
with smaller instrument sets; thereby reducing the amount of
inventory a hospital needs to sterilize, set up and store. This
platform will reduce sterilization costs associated with the
procedure, including:
- ~44% fewer instruments to sterilize compared with
the full-sized configurations.
- 91% fewer items to sterilize compared with the
full-sized instrument and implant sets.
- 67% reduction in number of cases to sterilize
compared with the full-sized instrument and implant sets.
"Healthcare systems are under intense economic
challenges, and Spine Essentials is an example of how Medtronic can
bring value to spine surgery by optimizing costs and efficiency,"
said Doug King, senior vice president and president of Medtronic's
Spinal business, which is part of the Restorative Therapies Group
at Medtronic. "We're committed to delivering successful patient
outcomes more efficiently, but we can't do it alone which is why
Spine Essentials was developed with the input of physicians and
hospitals."
Spine Essentials incorporates technology developed
by Gary K. Michelson, M.D.
About Medtronic's Spinal Business
We shape spine surgery for the better - delivering smarter
procedures and healing biologics. As a global leader, we partner
with other healthcare stakeholders to accelerate innovations that
create surgical efficiencies and improve outcomes for more
patients. More information about spinal treatments can be found at
our patient-education website, www.back.com.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 85,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements
are subject to risks and uncertainties such as those described in
Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from
anticipated results.
-end-
Contacts:
Victor Rocha
Public Relations
+1-901-399-2401
Ryan Weispfennig
Investor Relations
+1-763-505-4626
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
HUG#2013621
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024